160 related articles for article (PubMed ID: 5394460)
1. [Metabolism of HB 419 in animals].
Heptner W; Kellner HM; Christ O; Weihrauch D
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1400-4. PubMed ID: 5394460
[No Abstract] [Full Text] [Related]
2. [Resorption, excretion and metabolism after intravenous and oral administration of HB 419-14C in man].
Rupp W; Christ O; Heptner W
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1428-34. PubMed ID: 5394466
[No Abstract] [Full Text] [Related]
3. [Resorption, distribution and excretion after administration of 14C-labelled HB 419 in rabbits, rats and dogs].
Kellner HM; Christ O; Rupp W; Heptner W
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1388+. PubMed ID: 5394459
[No Abstract] [Full Text] [Related]
4. [Pharmacokinetics of a new highly effective hypoglycemic sulfonylurea derivative].
Heptner W; Christ O; Rupp W; Kellner HM
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():105-15. PubMed ID: 5371306
[No Abstract] [Full Text] [Related]
5. [Glucose and HB 419-concentration in blood as well as HB 419-excretion in urine after single oral application of HB 419-14C].
Schmidt HA; Petrides P
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1422-8. PubMed ID: 5394465
[No Abstract] [Full Text] [Related]
6. [Pharmacology of HB 419, a new strongly effective oral antidiabetic].
Bänder A; Pfaff W; Schmidt FH; Stork H; Schröder HG
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1363-8. PubMed ID: 5394454
[No Abstract] [Full Text] [Related]
7. [Pharmacokinetic studies with the new antidiabetic HB 419 in animals].
Schmidt FH; Kohler KF; Stork H; Hajdú P
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1386-8. PubMed ID: 5394458
[No Abstract] [Full Text] [Related]
8. [Clinico-pharmacological studies on the blood sugar reducing effect of HB 419 in healthy people].
Betzien G
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1421-2. PubMed ID: 5394464
[No Abstract] [Full Text] [Related]
9. [Observations on the mechanism of action of the hypoglycemic effective sulfonylurea preparation HB 419].
Hellman B; Idahl LA; Tjälve H; Danielsson A; Lernmark A
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1472-6. PubMed ID: 4899091
[No Abstract] [Full Text] [Related]
10. [Effect of tolbutamide and HB 419 on blood glucose, plasma-corticosterone and liver glycogen in rats].
Hasselblatt A; Panten U; Poser W
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1483-7. PubMed ID: 5394471
[No Abstract] [Full Text] [Related]
11. Pharmacokinetics of glipizide in man: influence of renal insufficiency.
Balant L; Zahnd G; Gorgia A; Schwarz R; Fabre J
Diabetologia; 1973 Sep; ():331-8. PubMed ID: 4772979
[No Abstract] [Full Text] [Related]
12. 14 C-warfarin excretion in the rat.
Losito R; Rousseau MA
Thromb Diath Haemorrh; 1972 Apr; 27(2):300-8. PubMed ID: 4558992
[No Abstract] [Full Text] [Related]
13. [Tolerance test of HB 419 in animal experiments].
Hebold G; Scholz J; Schütz E; Czerwek H; Brunk R
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1404-13. PubMed ID: 5394461
[No Abstract] [Full Text] [Related]
14. [Effect of HB 419 on the metabolism of the isolated perfused liver of normal and alloxan-diabetic rats].
Willms B; Jellinghaus M; Kleineke J; Söling HD
Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1479-83. PubMed ID: 5394470
[No Abstract] [Full Text] [Related]
15. [Pharmacokinetics of glibornuride].
Rentsch G; Schmidt HA; Rieder J
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2209. PubMed ID: 4679250
[No Abstract] [Full Text] [Related]
16. [Pharmacokinetics of blood glucose lowering biguanide derivatives].
Mehnert H
Acta Diabetol Lat; 1969 Sep; 6 Suppl 1():137-42. PubMed ID: 4906018
[No Abstract] [Full Text] [Related]
17. [Metabolism of thiazanol in rats and dogs].
Queisnerová M; Zikmund E; Svátek E
Cesk Farm; 1971 Jan; 20(1):15-7. PubMed ID: 5546594
[No Abstract] [Full Text] [Related]
18. [Urea metabolism. 5. Analysis of excretory products].
Harmeyer J; Birck R; Jezková D
Z Tierphysiol Tierernahr Futtermittelkd; 1972 Sep; 30(2):92-100. PubMed ID: 4648401
[No Abstract] [Full Text] [Related]
19. [Chemistry, toxicology, pharmacodynamics and mechanism of action of biguanides].
Ezechieli S
Clin Ter; 1970 Aug; 54(4):351-80. PubMed ID: 4992475
[No Abstract] [Full Text] [Related]
20. The absorption, distribution, excretion, and biotransformation of the carcinostatic 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in animals.
Oliverio VT; Vietzke WM; Williams MK; Adamson RH
Cancer Res; 1970 May; 30(5):1330-7. PubMed ID: 4987693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
